Resource type: Peer-reviewed journal
Total results with these characteristics: 633
- Comparison of Cost-of-Illness with Willingness-to-Pay Estimates to Avoid Shigellosis: Evidence from China
Published in Health Policy and Planning, this compares cost-of-illness (COI) with stated preference estimates of willingness-to-pay associated with shigellosis in a rural area of China to evaluate the economic benefits of disease …
Author: Guh S, Xingbao C, Poulos C, et al.
- Comparison of the Immunogenicity and Safety of Measles Vaccine Administered Alone or With Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine in Philippine Infants
This article, published in the journal Vaccine, presents data generated through a PATH-supported study that demonstrated safe and immunogenic coadministration of measles vaccine and the live, attenuated japanese …
Author: Gatchalian S, Yao Y, Zhoub B, et al.
- Concomitant Administration of Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) and Measles, Mumps, Rubella (MMR) Vaccine: Randomized Study in Toddlers in Taiwan
This article, published in Vaccine, reports on a study that examined the safety and efficacy of administering Japanese encephalitis vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine six weeks apart or concomitantly in children aged 12 to 18 …
Author: Huang L-M, Lin T-Y, Chiu C-H, et al.
- Conducting Vaccine Clinical Trials in Sub-Saharan Africa: Operational Challenges and Lessons Learned From the Meningitis Vaccine Project
The Meningitis Vaccine Project (MVP) was established with the goal of developing, testing, licensing, and introducing an affordable group A meningococcal conjugate vaccine for Africa. The authors of this article, published in Vaccine, describe the …
Author: Marchetti E, Mazarin-Diop V, Chaumont J, et al.
- Confirmation of Japanese Encephalitis as an Endemic Human Disease Through Sentinel Surveillance in Indonesia
Japanese encephalitis (JE) results in significant mortality and disability in children in Asia. In Indonesia, despite recognition of JE virus transmission, reports of human disease have been few and from limited geographic areas. Hospital-based …
Author: Ompusunggu S, Hills S, Sembiring Maha M, et al.
- Conjugate Vaccine Introduction in the African Meningitis Belt: Meeting Surveillance Objectives
This article, published in Tropical Medicine & International Health, asserts that surveillance systems and techniques for diagnosing bacterial meningitis and pneumococcal disease in the African meningitis belt have improved greatly over the …
Author: Mueller JE
- Conjugate Vaccines
This review, published in Expert Review of Vaccines, looks at what has been learned from developing conjugate vaccines against Haemophilus influenzae type b, Streptococcus pneumoniae, and group C Neisseria meningitidis that could be useful for the …
Author: Lockhart S
- Conjugate Vaccines and the Carriage of Haemophilus influenzae type b
Many junior doctors today have not had occasion to treat a child for Hib disease. The remarkable absence of cases of this disease is due to the use of conjugate vaccines. In countries with established Hib vaccination programs the incidence of …
Author: Barbour M
- Continuing Increases in Autism Reported to California's Developmental Services System
This study, published in the journal Archives of General Psychiatry, evaluates the rates of autism in California following the discontinued use of thimerosal in childhood vaccines. ABSTRACT ONLY. (Learn how users in developing countries …
Author: Schechter R, Grether J
- The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II
To assess whether certain serogroups of Streptococcus pneumoniae are preferentially associated with specific disease manifestations, we analyzed all recent pneumococcal disease studies and assessed the relative frequency of isolation of each …
Author: Hausdorff WP, Bryant J, Paradiso P, Siber G
- Control of Japanese Encephalitis--Within Our Grasp?
The article, from the New England Journal of Medicine, provides an up-to-date summary of JE disease incidence, epidemiology, and vaccines against JE.
Author: Solomon T
- Coordinated Surveillance and Detection of Pneumococcal and Haemophilus influenzae type b (Hib) Disease in Developing Countries
This supplemental issue of Clinical Infectious Diseases provides numerous articles on the surveillance and detection of pneumococcal and Haemophilus influenzae type b disease in developing countries. Topics include progress and challenges in disease …
Author: Black S, Knoll MD, eds.
- Correlates of Protection: Novel Generations of Influenza Vaccines
This article, published in the journal Vaccine, reviews potential correlates of protection against influenza and discusses some of the vaccination strategies that could result in optimal protection against epidemic and pandemic influenza. ABSTRACT …
Author: Rimmelzwaan GF, McElhaney JE
- Cost and Effectiveness Analysis of Immunization Service Delivery Support in Andhra Pradesh, India
Published in the Bulletin of the World Health Organization, this paper offers the first attempt to quantitatively evaluate the supportive supervision framework in Andhra Pradesh, India.
Author: Suraratdecha C, Ramana V, Kaipilyawar S, et al.
- The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review
Invasive meningococcal disease (IMD) is a serious disease with a rapid onset, high mortality rate, and risk of long-term complications. The authors of this article, published in Pharmacoeconomics, systematically reviewed the literature on the costs …
Author: Anonychuk A, Woo G, Vyse A, Demarteau N, Tricco AC
- A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison Between Rotarix and RotaTeq Vaccines
The authors of this article, published in PLoS ONE, applied cost-effectiveness modeling and a cold-chain impact assessment to aid decision-making on rotavirus vaccine introduction in Kenya. They conclude that use of either vaccine is cost-effective, …
Author: van Hoek AJ, Ngama M, Ismail A, et al.
- A Cost Function Analysis of Shigellosis in Thailand
This article, published in Value in Health, discusses a study to develop a cost function model to estimate the public treatment cost of shigellosis patients in Thailand. The study was an incidence-based cost-of-illness …
Author: Riewpaiboon A, Youngkong S, Sreshthaputra N, et al.
- The Cost of Unsafe Injections
Unsafe injection practices are associated with substantial morbidity and mortality. Annually more than 1.3 million deaths and US$535 million in expenses are estimated to be due to unsafe injection practices. This article, published in the Bulletin …
Author: Miller MA, Pisani E
- Cost-Effectiveness and Economic Benefits of Vaccines in Low- and Middle-Income Countries: A Systematic Review
This review, published in Vaccine, documents the available evidence showing that vaccination in low- and middle-income countries brings important economic benefits. The cost-effectiveness studies reviewed suggest to policy makers that vaccines are …
Author: Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS
- Cost-Effectiveness and Potential Impact of Rotavirus Vaccination in the United States
This study, published in the journal Pediatrics, examines the costs and benefits of routine rotavirus vaccination for infants in the US, using a hypothetical cohort of unvaccinated infants. Researchers determined that, at current prices, …
Author: Widdowson MA, Meltzer MI, Zhang X, et al.
- Cost-Effectiveness of a New Rotavirus Vaccination Program in Pakistan: A Decision Tree Model
This article, published in Vaccine, reports on the expected public health impact of a national rotavirus vaccination program in Pakistan by performing a cost-effectiveness study from the perspective of the health care system. Across a range of …
Author: Patel HD, Roberts ET, Constenla DO
- Cost-Effectiveness of Childhood Rotavirus Vaccination in Taiwan
This paper, published in the journal Vaccine, investigates whether routine infant immunization with either currently licensed rotavirus vaccine could be cost-effective in Taiwan. The authors modeled specific disease outcomes …
Author: Wu CL, Yang YC, Huang LM, Chen KT
- Cost-effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States
This article, published in the journal Pediatrics, discusses a study to evaluate and compare the projected health and economic impact of meningococcal conjugate A/C/Y/W-135 (MCV-4) vaccination of adolescents, toddlers, and infants in the United …
Author: Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, Rosenstein NE; ABCs Team
- Cost-Effectiveness of Female Human Papillomavirus Vaccination in 179 Countries: A PRIME Modelling Study
This article, published in The Lancet Global Health, reports on a modeling study that assessed the cost-effectiveness and health effects of vaccinating girls against human papillomavirus (HPV) before sexual debut in terms of burden of cervical …
Author: Jit M, Brisson M, Portnoy A, Hutubessy R
- Cost-Effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico
This study, published in BMC Infectious Diseases, developed a model to compare the cost and disease burden of rotavirus in unvaccinated children in Mexico. The study determined that it would be highly cost-effective to include rotavirus vaccine …
Author: Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R